Author: Beata Staszkow

VA Generic Coverage: How Veterans Affairs Formularies Control Prescription Costs and Access

Beata Staszkow
|
February 7
|
3

The VA formulary ensures veterans get affordable, effective generic medications with low copays. Learn how the three-tier system works, what drugs are covered in 2025, and how to navigate prescriptions through VA pharmacies.

China vs India Pharmaceutical Manufacturing: FDA Risks and Monitoring Explained

Beata Staszkow
|
February 5
|
3

China and India dominate global pharmaceutical manufacturing but face different regulatory risks. The FDA's monitoring shows India has better compliance with 100 approved plants versus China's 28. Learn why companies are shifting supply chains and how API dependency affects drug safety.

COPD Triple Inhaler Therapy: Reducing Exacerbations and Improving Management

Beata Staszkow
|
February 4
|
3

Triple inhaler therapy combines three medications for COPD management. Learn how it reduces exacerbations, who qualifies, and real-world pros and cons. Based on 2024 GOLD guidelines, this treatment is targeted for specific patients with frequent flare-ups and elevated eosinophil levels.

Progressive Multifocal Leukoencephalopathy Risk from Immunosuppressants: What You Need to Know

Beata Staszkow
|
February 3
|
6

PML is a rare but deadly brain infection triggered by the JC virus in people taking immunosuppressants. Learn which drugs carry the highest risk, how to detect PML early, and what steps can save your life.

ANDA Process: Legal Requirements for Generic Drug Approval in the U.S.

Beata Staszkow
|
January 30
|
7

The ANDA process lets generic drug makers get FDA approval by proving bioequivalence to brand-name drugs, cutting costs and speeding access. Legal requirements include identical active ingredients, strict CMC standards, patent certifications, and GDUFA fees.

Mental Illness and Medication Interactions: Navigating Complex Polypharmacy

Beata Staszkow
|
January 28
|
10

Psychiatric polypharmacy-taking multiple mental health meds at once-is common but often risky. Learn why it happens, who’s most at risk, and how to safely reduce unnecessary drugs to improve health and quality of life.

Shoulder Pain? Here’s How Rotator Cuff Injuries, Bursitis, and Rehab Actually Work

Beata Staszkow
|
January 27
|
10

Rotator cuff pain and shoulder bursitis are common but often misunderstood. Learn how to treat them without surgery, the rehab steps that actually work, and what to avoid to prevent recurrence.

Counterfeit Medication Red Flags: What to Watch For

Beata Staszkow
|
January 26
|
9

Learn the top signs of counterfeit medication - from suspicious pricing to fake packaging and dangerous ingredients - and how to protect yourself from deadly fake pills sold online.

Medicare Part D Drug Coverage Explained for Patients in 2025

Beata Staszkow
|
January 26
|
12

Medicare Part D in 2025 now caps out-of-pocket drug costs at $2,000 annually, eliminating the donut hole. Learn how the new coverage phases work, how to choose a plan, and what you still need to watch for.

How to Prevent Pediatric Dispensing Errors with Weight-Based Checks

Beata Staszkow
|
January 22
|
9

Pediatric medication errors often stem from weight calculation mistakes. Learn how weight-based verification at every step-prescribing, dispensing, and administering-can prevent life-threatening dosing errors in children.